Eli Lilly Pharmaceutical

Eli Lilly and Company Limited is the UK affiliate of major American pharmaceutical manufacturer, Eli Lilly and Company of Indianapolis. This affiliate is one of the UK's top pharmaceutical companies, with a research and development centre, two manufacturing sites and a distribution centre which exports medicines to all parts of the world.

Lilly medicines treat schizophrenia, diabetes, cancer, osteoporosis, attention deficit hyperactivity disorder, erectile dysfunction, severe sepsis, depression, infections, bipolar disorder and many other diseases.

Eli Lilly and Company is one of the world's largest research based pharmaceutical companies dedicated to creating and delivering innovative pharmaceutical health care solutions that enable people to live longer, healthier and more active lives.

Eli Lilly research and development efforts constantly strive to address urgent, unmet medical needs and to replace more expensive and invasive medical treatments. As Eli Lilly pursue this goal we endeavour to reduce the cost of disease thereby creating significant value to health care providers and in turn benefits to patients.

Lilly employs more than 44,000 people world-wide and markets its products in 143 countries.

The UK has a proud history of medical discovery and the Lilly Research & Development facility at Erl Wood Manor, Windlesham, Surrey continues this tradition. The Lilly Research Centre founded in 1967 has served as a centre of excellence contributing to the development of much needed new medicines. The most recent breakthrough was in the discovery and development of an innovative and very successful treatment for schizophrenia. This medicine is already a huge success for patients across the world. More recently this site won Lilly the "Queen's Award for Innovation" for the discovery and commercialisation of Zyprexa®.

Multidisciplinary development teams are dedicated to meeting unmet medical needs across a range of specialist therapeutic areas including disorders of the central nervous system, diabetes and cancer.

Lilly UK - Sales & Marketing

Lilly UK is one of the largest providers of medicines to the UK National Health Service. Lilly's medicines are currently treating schizophrenia, diabetes, bipolar disorder, stress urinary incontinence, erectile dysfunction, depression, cancer, heart disease, pain, infections and gastric disorders across the UK and bringing relief to millions of people.

Headquartered in Basingstoke, Hampshire with employees throughout England, Scotland, Wales and Northern Ireland the company is committed to creating value adding relationships throughout the NHS. This relationship is not simply about selling medicines it is all about adding value to the health care delivery process for the optimum benefit of the patient and the health care professional.

Lilly's continuing success is based upon working in partnership with health care professionals, listening to patients and responding quickly to changing circumstances. The company believes that the prevention and treatment of disease is about much more than providing effective medicines. That is why Lilly takes a lead in providing a wide range of support services such as health outcome data, specialist product services, information packs, and non product related services such as business management training.

The National Health Service is constantly changing and Lilly has been at the forefront of adapting to its changing customer's needs. The company works closely with NHS managers on best practice in health management, optimising health outcomes and assisting in effective clinical management to ensure that the best possible value can be derived from the company's medicines.

Discovering and delivering innovative ground breaking medicines to the patient is an expensive and lengthy process - more than £300 million and 10 years for each new medicine. However modern medicines often reduce the cost of disease to society as a whole. The introduction of anti-ulcer drugs in the 'eighties almost totally eradicated the need for expensive surgery. The advent of effective medicines for HIV has meant the closure of hospital wards and subsequent economic savings. Of course Lilly does not believe such claims should be taken at face value and invests in health economic evaluative research to demonstrate the true value of its innovative medicines.

Latest Eli Lilly pharmaceutical news

Eli Lilly further information:
www.lilly.co.uk / www.lilly.com/ / Eli Lilly news

Page last updated: 11/06/08

Pharmaceutical product information and articles
Get the latest Pharmaceutical drug reviews, reports & pharmaceutical intelligence


Contact \| Suggest Pharmaceutical Resource	Copyright © Net Media Marketing. All rights reserved.

Pharmaceutical jobs, Medical / Pharmaceutical sales jobs, Pharmaceutical Company, Pharmaceutical, Pharmajobs, Pharma jobs, Pharmaceutical sales Pharmaceutical jobs, Healthcare sales, Laboratory sales, Veterinary sales jobs, Dental sales jobs, Trainee sales jobs, Nurse Advisor jobs, Sales Management, Pharma Marketing, Senior Management, Regulatory & Clinical & Scientific sales jobs